Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,836 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06888427Recruiting
Sleep after surgery for adults
This study looks at how sleep changes for adults after surgery under general anesthesia. Researchers want to understand patients' experiences with sleep during recovery.
Nice, Alpes-MaritimesAges 18 years+ - NCT06882538Recruiting
Mindfulness program for schizophrenia patients
This study tests if a one-on-one mindfulness-based psychoeducation program can help reduce internalized stigma and promote healthy lifestyle behaviors in people with schizophrenia. It aims to provide a supportive approach to improve well-being.
Kastamonu, CentralAges 18 years+ - NCT06883448Recruiting
Home monitoring for pulmonary fibrosis
This trial studies whether using a home monitoring program helps people with pulmonary fibrosis track their condition. It aims to make care easier and catch changes early.
AmsterdamAges 18 years+ - NCT06883526RecruitingPhase 1/Phase 2
ZG005 plus gecacitinib for lymphoma that has returned or not responded
This trial tests a combination of two drugs, ZG005 and gecacitinib, for people with lymphoma that has come back or hasn't gotten better with prior treatment. The goal is to see if this combination can help shrink or control the cancer.
Hangzhou, ZhejiangAges 18 years+ - NCT06883604Recruiting
Proton therapy for early-stage Hodgkin lymphoma
This trial tests if proton beam radiation can effectively treat Hodgkin lymphoma while reducing side effects. It is for people with early-stage disease who have already completed chemotherapy and need radiation.
GothenburgAges 18–60 - NCT06883864Recruiting
Ablation for leaky valve with constant atrial fibrillation
This study tests whether a catheter ablation procedure (a way to fix abnormal heart rhythms) can help people who have both constant atrial fibrillation and severe mitral regurgitation (a leaky heart valve). It is for people whose heart valve leak is caused by the rhythm problem, not by valve damage.
Hefei, AnhuiAges 18–80 - NCT06884358Recruiting
Heart and exercise capacity in Fabry disease
This study looks at how Anderson-Fabry disease affects your heart and ability to exercise. Researchers want to understand this better by testing your heart function and how well you can do physical activity.
Brescia, BresciaAges Any age - NCT06884631Recruiting
Heart failure risk assessment with exercise test and kidney health
This study uses a special exercise test, along with heart and kidney measurements, to better predict risks for people with heart failure. It may help your doctors understand your condition and choose the best care for you.
Milan, ItalyAges 18 years+ - NCT06885164Recruiting
Remote heart monitoring for heart failure patients
This trial tests whether remote monitoring of heart function can help manage heart failure. It may be an option if you have symptoms like shortness of breath or fatigue (NYHA class II or higher) and are between 18 and 90 years old.
Aalborg, DenmarkAges 18–90 - NCT06885502Recruiting
Stroke rehab with motor and cognitive assistance
This trial tests a personalized system that helps stroke survivors improve arm movement and thinking skills. It uses a device that guides your arm and mind through exercises, and you may benefit if you had a stroke at least 3 months ago and have some arm function.
Cluj-NapocaAges 18 years+ - NCT06885476Recruiting
NK cell infusion for AML patients with minimal cancer left
This trial tests if giving special immune cells from a donor can clear leftover leukemia cells in patients who are in remission but still have traces of cancer after chemotherapy.
Bologna, BOAges 18 years+ - NCT06885541Recruiting
Measuring internal tremors in Parkinson's patients
This study uses a device on your body to detect internal tremors (tiny vibrations you may feel inside) in Parkinson's disease. It helps researchers understand these tremors better and compare them to people without Parkinson's.
Toulouse, OccitanieAges 18–80 - NCT06885710RecruitingPhase 1
T cell therapy with antivirals for chronic hepatitis B
This study tests a new treatment that uses your own immune cells (T cells) modified to attack the hepatitis B virus, combined with standard antiviral medication. It is for people with chronic hepatitis B who have a specific HLA type and no advanced liver scarring.
ShanghaiAges 18–65 - NCT06885814RecruitingPhase 2
Adebrelimab with chemoradiation for advanced esophageal cancer
This trial tests a drug called adebrelimab (an immunotherapy) combined with chemotherapy and radiation for people with advanced esophageal cancer that cannot be removed by surgery or has come back after surgery. It aims to see if the combination is safe and effective.
Guangzhou, GuangdongAges 18–75 - NCT06885827Recruiting
Vitamin mix for people with glaucoma
This trial tests whether taking a daily mix of B vitamins (B6, B9, B12) and choline can help slow vision loss in people with certain types of glaucoma. You would take the vitamins or a placebo (inactive pill) for up to 2 years.
Stockholm, Stockholm CountyAges 18 years+ - NCT06885879Recruiting
Studying ctDNA changes after radiation for liver cancer
This trial studies how radiation therapy (SBRT) affects a DNA fragment in the blood called ctDNA in people with liver cancer. By tracking ctDNA changes, doctors hope to better understand how well the treatment is working and possibly predict outcomes earlier.
Hong KongAges 18 years+ - NCT06886425Recruiting
Study of how azacytidine works in blood cancers
This study looks at how certain enzymes in your body affect the way a drug called azacytidine works against blood cancers like acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). The goal is to better understand who might benefit most from this treatment.
MarseilleAges 18 years+ - NCT06887088RecruitingPhase 2
Study of encorafenib, binimetinib, cemiplimab, and fianlimab for melanoma with brain metastases
This trial tests a combination of targeted drugs (encorafenib and binimetinib) followed by immunotherapy (cemiplimab and fianlimab) for people with advanced melanoma that has spread to the brain and is causing symptoms. The goal is to see if this approach can shrink tumors and help control the disease.
A Coruña, A CoruñaAges 18 years+ - NCT06887101Recruiting
Stress and heart risks in peripheral artery disease
This study looks at how stress affects heart and blood vessel events in people with peripheral artery disease (PAD). It aims to help understand if stress plays a role in worsening PAD or causing related problems like heart attacks or strokes.
EssenAges 18 years+ - NCT06887114Recruiting
Lumbar back therapy for better walking and balance after stroke
This study tests a gentle, hands-on therapy called Mulligan Mobilization for the lower back. It may help improve walking, balance, and body awareness after a stroke.
AnkaraAges 30–65 - NCT06887127RecruitingPhase 3
Long-term safety study of TLL-018 for rheumatoid arthritis patients
This study offers continued access to TLL-018 for people with rheumatoid arthritis who completed the earlier study (TLL-018-301). It checks long-term safety and helps researchers understand if the medicine remains effective over time.
Beijing, Beijing MunicipalityAges 18–75 - NCT06887140Recruiting
Heart-lung function test in sepsis patients
This study uses an ultrasound of the heart (echocardiogram) to check how well the right side of your heart is working with your lungs during sepsis. The goal is to see if this measurement can help doctors predict how patients will recover.
Ho Chi Minh CityAges 18 years+ - NCT06887218RecruitingPhase 2
Testing a new combination for advanced colorectal cancer
This trial tests a combination of two drugs, regorafenib and 5-FU with leucovorin, for people with colorectal cancer that has spread and has not responded to at least two previous treatments. The goal is to see if this new mix can help shrink or control the cancer.
Houston, TexasAges 18 years+ - NCT06887244Recruiting
Nurse phone support before colonoscopy
This trial studies whether a nurse phone call before an elective colonoscopy can improve the procedure experience, reduce anxiety, and lower financial stress.
NaplesAges 18–80
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,836 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.